Get the Stockscreener App
2.73
5.86%
-0.17
After Hours:
2.73
Compass Therapeutics Inc Stock (CMPX) Forecast
The Compass Therapeutics Inc (CMPX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.5665, representing a -42.62% decrease from the current price of $2.73. The highest analyst price target is $2.068, and the lowest is $1.065.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CMPX Price Target
Average 2.1947
(-19.61% Downside)
Is Compass Therapeutics Inc (CMPX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 43.80 | Neutral |
| STOCH(9,6) | 12.96 | Buy |
| STOCHRSI(14) | 3.3204 | Buy |
| MACD(12,26) | 0.0477 | Sell |
| ADX(14) | 34.83 | Sell |
| William %R | -91.22 | Buy |
| CCI(14) | -97.92 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.015
Sell
|
3.0043
Sell
|
| MA20 |
3.243
Sell
|
3.0366
Sell
|
| MA50 |
2.5386
Buy
|
2.6939
Buy
|
| MA100 |
2.1094
Buy
|
2.2968
Buy
|
| MA200 |
1.7032
Buy
|
1.9946
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, CMPX could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 6 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on CMPX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 43.8 indicates that CMPX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 12.96 indicates that CMPX is oversold. This indicates that CMPX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 3.3204 indicates that CMPX is oversold. This suggests that CMPX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 34.83 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -97.92 indicates that CMPX is still oversold but not to an extreme extent.
Long-term CMPX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Compass Therapeutics Inc financial reports and earnings history, Compass Therapeutics Inc (CMPX) stock could reach $1.8878 by 2030, $4.5348 by 2040 and $15.70 by 2050. See the projected annual prices until 2050 of the Compass Therapeutics Inc stock below:
- Compass Therapeutics Inc (CMPX) is expected to reach an average price of $2.6199 in 2035, with a high prediction of $2.5599 and a low estimate of $2.4585. This indicates an $-4.03% rise from the last recorded price of $2.73.
- Compass Therapeutics Inc (CMPX) stock is projected to chart a bullish course in 2040, with an average price target of $4.7248, representing an $73.07% surge from its current level. The forecast ranges from a conservative $4.7092 to a sky-high $4.5348.
- Our analysts predict Compass Therapeutics Inc (CMPX) to jump 300.62% by 2045, soaring from $11.04 to an average price of $10.94, potentially reaching $11.14. While $11.04 is the low estimate, the potential upside is significant.
- Compass Therapeutics Inc (CMPX) stock is expected to climb by 2050, reaching an average of $16.25, a $495.09% jump from its current level. However, a wide range of estimates exists, with high and low targets of $15.70 and $6.5077, respectively, highlighting the market's uncertainty.
Compass Therapeutics Inc Stock (CMPX) Year by Year Forecast
Compass Therapeutics Inc Stock (CMPX) Price Forecast for 2025
Compass Therapeutics Inc Stock (CMPX) is expected to reach an average price of $2.1817 in 2025, with a high prediction of $4.1666 and a low estimate of $0.1968. This indicates an -20.08% fall from the last recorded price of $2.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $1.448 | $1.065 | $2.068 | -46.96% |
| May, 2025 | $1.5476 | $0.2228 | $1.6776 | -43.31% |
| June, 2025 | $2.4573 | $1.0925 | $2.4573 | -9.99% |
| July, 2025 | $3.4343 | $2.1847 | $3.5593 | +25.80% |
| August, 2025 | $3.554 | $2.5092 | $4.1666 | +30.18% |
| September, 2025 | $2.4936 | $1.7462 | $4.0888 | -8.66% |
| October, 2025 | $2.4007 | $2.2133 | $2.8035 | -12.06% |
| November, 2025 | $2.0203 | $1.7729 | $2.5781 | -25.99% |
| December, 2025 | $1.5674 | $1.3774 | $2.185 | -42.59% |
Compass Therapeutics Inc Stock (CMPX) Price Forecast for 2026
The predicted value for Compass Therapeutics Inc (CMPX) in 2026 is set at an average of $1.2388. Estimates vary from a peak of $2.3145 to a trough of $0.1632, indicating an -54.62% surge from the present price of $2.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.857 | $1.2498 | $2.2418 | -31.98% |
| February, 2026 | $1.8367 | $1.3969 | $2.3145 | -32.72% |
| March, 2026 | $1.6663 | $1.5689 | $2.1815 | -38.96% |
| April, 2026 | $1.3034 | $1.2386 | $1.7938 | -52.26% |
| May, 2026 | $1.143 | $1.1106 | $1.4508 | -58.13% |
| June, 2026 | $0.8027 | $0.6727 | $1.2579 | -70.60% |
| July, 2026 | $0.5698 | $0.5348 | $0.9201 | -79.13% |
| August, 2026 | $0.4994 | $0.2994 | $0.8246 | -81.71% |
| September, 2026 | $0.5365 | $0.4465 | $0.7265 | -80.35% |
| October, 2026 | $0.7861 | $0.3113 | $0.9861 | -71.20% |
| November, 2026 | $0.2258 | $0.1858 | $0.8334 | -91.73% |
| December, 2026 | $0.9428 | $0.1632 | $1.0154 | -65.46% |
Compass Therapeutics Inc Stock (CMPX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Compass Therapeutics Inc (CMPX) is $1.3256, with a high forecast of $2.2191 and a low forecast of $0.4321. This indicates an -51.44% decrease from the last price of $2.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.0525 | $0.8102 | $1.3976 | -61.45% |
| February, 2027 | $0.5521 | $0.4321 | $1.0599 | -79.78% |
| March, 2027 | $0.7104 | $0.4952 | $0.7269 | -73.98% |
| April, 2027 | $0.8211 | $0.8207 | $0.4611 | -69.92% |
| May, 2027 | $1.0518 | $0.7666 | $0.6562 | -61.47% |
| June, 2027 | $1.3877 | $1.4069 | $1.9125 | -49.17% |
| July, 2027 | $2.0484 | $1.5028 | $1.6182 | -24.97% |
| August, 2027 | $2.2491 | $2.3339 | $2.2191 | -17.62% |
| September, 2027 | $2.0649 | $2.0998 | $2.1143 | -24.36% |
| October, 2027 | $0.4657 | $0.9857 | $1.8201 | -82.94% |
| November, 2027 | $0.9364 | $0.606 | $0.8565 | -65.70% |
| December, 2027 | $0.5522 | $0.6722 | $0.6569 | -79.77% |
Compass Therapeutics Inc Stock (CMPX) Price Forecast for 2028
In 2028, Compass Therapeutics Inc (CMPX) is projected to reach an average price of $1.3508, with a high projection of $2.6832 and a low estimate of $0.0185. This indicates an -50.52% fall from the last price of $2.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.293 | $0.6974 | $0.6076 | -89.27% |
| February, 2028 | $0.3337 | $0.3133 | $0.2337 | -87.78% |
| March, 2028 | $0.3295 | $0.284 | $0.7644 | -87.93% |
| April, 2028 | $0.0598 | $0.0185 | $0.2548 | -97.81% |
| May, 2028 | $1.0839 | $0.0646 | $1.7942 | -60.30% |
| June, 2028 | $2.4432 | $1.0183 | $2.6832 | -10.51% |
| July, 2028 | $0.7925 | $0.2925 | $2.658 | -70.97% |
| August, 2028 | $1.1166 | $0.6573 | $1.7123 | -59.10% |
| September, 2028 | $0.5459 | $0.3859 | $1.1814 | -80.00% |
| October, 2028 | $0.6452 | $0.2455 | $0.9207 | -76.37% |
| November, 2028 | $0.6143 | $0.0348 | $0.9215 | -77.50% |
| December, 2028 | $0.3636 | $0.0987 | $1.0089 | -86.68% |
Compass Therapeutics Inc Stock (CMPX) Price Forecast for 2029
The 2029 price forecast for Compass Therapeutics Inc Stock (CMPX) is $0.4601 on average, with a high prediction of $0.913 and a low estimate of $0.00716. This represents an -83.15% decrease from the previous price of $2.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.4127 | $0.3079 | $0.913 | -84.88% |
| February, 2029 | $0.422 | $0.00716 | $0.562 | -84.54% |
| March, 2029 | $0.0187 | $0.0337 | $0.4168 | -99.31% |
| April, 2029 | $0.1994 | $0.0391 | $0.1987 | -92.69% |
| May, 2029 | $0.2753 | $0.3998 | $0.275 | -89.92% |
| June, 2029 | $0.646 | $0.4908 | $0.3757 | -76.34% |
| July, 2029 | $0.4467 | $0.5416 | $0.4467 | -83.64% |
| August, 2029 | $0.4326 | $0.4669 | $0.3748 | -84.15% |
| September, 2029 | $0.7033 | $0.4078 | $0.5533 | -74.24% |
| October, 2029 | $0.1492 | $0.2492 | $0.6606 | -94.53% |
| November, 2029 | $0.2601 | $0.0253 | $0.4553 | -90.47% |
| December, 2029 | $0.3406 | $0.0949 | $0.3849 | -87.52% |
Compass Therapeutics Inc Stock (CMPX) Price Forecast for 2030
Compass Therapeutics Inc Stock (CMPX) is expected to reach an average price of $2.1774 in 2030, with a high forecast of $4.0286 and a low forecast of $0.3261. This signifies an -20.24% decrease from the last price of $2.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.4378 | $0.3261 | $1.8878 | -10.70% |
| February, 2030 | $2.8188 | $2.7711 | $2.3955 | +3.25% |
| March, 2030 | $2.4799 | $2.6799 | $2.5844 | -9.16% |
| April, 2030 | $3.9009 | $3.0377 | $3.631 | +42.89% |
| May, 2030 | $3.5098 | $3.3642 | $3.7887 | +28.56% |
| June, 2030 | $4.0908 | $3.9275 | $3.9808 | +49.85% |
| July, 2030 | $3.7897 | $3.8797 | $4.0286 | +38.82% |
| August, 2030 | $2.6607 | $2.9501 | $3.6574 | -2.54% |
| September, 2030 | $2.7318 | $2.334 | $2.1262 | +0.07% |
| October, 2030 | $2.2056 | $2.4906 | $2.5696 | -19.21% |
| November, 2030 | $2.3017 | $2.3484 | $2.2689 | -15.69% |
| December, 2030 | $2.1227 | $1.945 | $1.9394 | -22.24% |
3.13%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):